Impact of voxelotor discontinuation on patients with sickle cell disease

Documenti analoghi

• Alkaline phosphatase as a marker for painful vaso‐occlusive events and other acute complications in sickle cell disease
  di: Jin Han, et al.
  Pubblicazione: (2024)
• Granulocyte colony‐stimulating factor may improve engraftment in adults with sickle cell disease undergoing non‐myeloablative haematopoietic stem cell transplantation
  di: Shaoshi Zhu, et al.
  Pubblicazione: (2025)
• Systemic lupus erythematosus‐associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice
  di: Urshita Sinha, et al.
  Pubblicazione: (2025)
• The clinical spectrum of HbSC sickle cell disease‐not a benign condition
  di: M. Nelson, et al.
  Pubblicazione: (2024)
• Twin pregnancy in patients with sickle cell disease: A French cohort study
  di: Edouard Leyne, et al.
  Pubblicazione: (2025)